keyword
https://read.qxmd.com/read/38690053/blastomas-of-the-digestive-system-in-adults-a-review
#1
REVIEW
Yu Liu, Tony El Jabbour, Jonathan Somma, Yukihiro Nakanishi, Saverio Ligato, Hwajeong Lee, Zhi-Yan Fu
Blastomas, characterized by a mixture of mesenchymal, epithelial, and undifferentiated blastematous components, are rare malignant neoplasms originating from precursor blast cells. This review focuses on digestive system blastomas in adult patients, including gastroblastoma, hepatoblastoma, and pancreatoblastoma. Gastroblastoma is a biphasic, epitheliomesenchymal tumor, with only sixteen cases reported to date. In addition to the characteristic histology, metastasis-associated lung adenocarcinoma transcript 1 - glioma-associated oncogene homolog 1 gene fusion is typical, although recently novel ewing sarcoma breakpoint region 1 - c-terminal binding protein 1 and patched 1 - glioma-associated oncogene homolog 2 fusions have been described...
April 27, 2024: World Journal of Gastrointestinal Surgery
https://read.qxmd.com/read/38689816/lhermitte-duclos-disease-in-a-51-year-old-patient
#2
Amro Abdelrahman, Shahd M Abass, Elhassan M Abdalla, Shuhal Elamin, Hany A Zaki, Khalid Y Fadul, Muhammad Abugabala, Mohamed Elgassim
Lhermitte-Duclos disease (LDD) is a rare, slow-growing neoplasm that develops in the brain's posterior fossa. It can appear as a single lesion or as part of Cowden's syndrome. We report the case of a 51-year-old female with a history of diabetes, hypertension, and a previously treated neuroendocrine tumor, who presented to the hospital after experiencing a generalized tonic-clonic seizure. Except for a tongue laceration, the neurological examination was unremarkable. Brain magnetic resonance imaging (MRI) showed a T2 left cerebellar hemisphere pseudomass lesion with iso-hyperintense signals suggestive of Lhermitte-Duclos disease...
July 2024: Radiology Case Reports
https://read.qxmd.com/read/38689169/value-of-surgical-cytoreduction-in-patients-with-small-intestinal-neuroendocrine-tumors-metastatic-to-the-liver-and-peritoneum
#3
JOURNAL ARTICLE
Hallbera Gudmundsdottir, Alessandro Fogliati, Travis E Grotz, Cornelius A Thiels, Susanne G Warner, Rory L Smoot, Mark J Truty, Michael L Kendrick, David M Nagorney, Thorvardur R Halfdanarson, Sean P Cleary, Patrick Starlinger
BACKGROUND: Cytoreductive hepatectomy can improve survival and symptoms of hormonal excess in patients with small intestinal neuroendocrine tumor (siNET) liver metastases, but whether to proceed when peritoneal metastases are encountered at the time of planned cytoreductive hepatectomy is controversial. METHODS: This was a retrospective review of patients who underwent surgical management of metastatic siNETs at Mayo Clinic between 2000 and 2020. Patients who underwent cytoreductive operation for isolated liver metastases or both liver and peritoneal metastases were compared...
April 30, 2024: Annals of Surgical Oncology
https://read.qxmd.com/read/38688618/neuroendocrine-breast-tumors-could-multigene-assays-help-in-guiding-treatment-decisions-case-presentation
#4
JOURNAL ARTICLE
Christos Markopoulos, Nikolaos Tsoulos, Konstantinos Agiannitopoulos, Evangelia Karagianni
BACKGROUND/AIM: Breast cancer remains the most prevalent type of cancer among women worldwide, and it remains the primary cause of cancer-related deaths in this demographic. Neuroendocrine breast cancer (NBC), an uncommon subtype comprising less than 1% of cases, typically occurs in older women and displays as a slow-growing, low-grade condition. NBC exhibits distinct histological patterns and immunohistochemical markers. Given the limited data on NBC, assays are required that will provide information on molecular profiling and assist in clinical decision making...
2024: In Vivo
https://read.qxmd.com/read/38687934/efficacy-and-safety-of-neoadjuvant-therapy-in-gastroenteropancreatic-neuroendocrine-neoplasms-a-systematic-review-and-meta-analysis
#5
JOURNAL ARTICLE
Yu Yan, Danzhu Wu, Weizhen Wang, Yajuan Lv, Liyuan Yang, Yinglong Liu, Peng Dong, Xinshuang Yu
OBJECTIVE: To determine the effectiveness and safety of neoadjuvant therapy in gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) and provide evidence-based suggestions for clinical treatment. METHODS: The Cochrane Library, Embase, PubMed, and Web of Science were searched for articles published that analyzed the effectiveness and safety of GEP-NEN-targeted neoadjuvant therapy before March 2023. A confidence interval (CI) of 95%, a subgroup analysis, heterogeneity, and effect size (ES) were analyzed, and a meta-analysis of the literature was performed using the Stata BE17 software...
April 1, 2024: Journal of Cancer Research and Therapeutics
https://read.qxmd.com/read/38686071/lethal-disseminated-intravascular-coagulation-induced-by-primary-and-metastatic-neuroendocrine-prostate-cancer
#6
Takashi Ando, Taro Sasaki, Makoto Naito
INTRODUCTION: Neuroendocrine prostate cancer has a poor prognosis. Although disseminated intravascular coagulation associated with malignancy can be lethal, it very rarely occurs among patients with primary neuroendocrine prostate cancer. CASE PRESENTATION: An 80-year-old man presented to our hospital with bloody sputum. Blood examination indicated disseminated intravascular coagulation. Serum levels of prostate-specific antigen and neuron-specific enolase were 44...
May 2024: IJU case reports
https://read.qxmd.com/read/38685721/evaluation-of-association-between-center-colorectal-neuroendocrine-neoplasm-volume-and-survival-among-patients-with-colorectal-neuroendocrine-carcinoma
#7
JOURNAL ARTICLE
Mohammed O Suraju, Kyle Freischlag, Andrew McKeen, Apoorve Nayyar, Dakota Thompson, Darren M Gordon, Aditi Mishra, Scott K Sherman, Paolo Goffredo, Imran Hassan
BACKGROUND: Although correlation between center volume and survival has been reported for several complex cancers, it remains unknown if this is true for colorectal neuroendocrine carcinomas (CRNECs). We hypothesized that higher center annual volume of colorectal neuroendocrine neoplasm resections would be associated with overall survival (OS) for patients with CRNECs. METHODS: Patients in the National Cancer Database diagnosed with stages I-III CRNEC between 2006 and 2018 and who underwent surgical resection were identified...
April 29, 2024: Journal of Surgical Oncology
https://read.qxmd.com/read/38685134/critical-updates-in-neuroendocrine-tumors-version-9-american-joint-committee-on-cancer-staging-system-for-gastroenteropancreatic-neuroendocrine-tumors
#8
JOURNAL ARTICLE
Aman Chauhan, Kelley Chan, Thorvardur R Halfdanarson, Andrew M Bellizzi, Guido Rindi, Dermot O'Toole, Phillip S Ge, Dhanpat Jain, Arvind Dasari, Daniel A Anaya, Emily Bergsland, Erik Mittra, Alice C Wei, Thomas A Hope, Ayse T Kendi, Samantha M Thomas, Sherlonda Flem, James Brierley, Elliot A Asare, Kay Washington, Chanjuan Shi
The American Joint Committee on Cancer (AJCC) staging system for all cancer sites, including gastroenteropancreatic neuroendocrine tumors (GEP-NETs), is meant to be dynamic, requiring periodic updates to optimize AJCC staging definitions. This entails the collaboration of experts charged with evaluating new evidence that supports changes to each staging system. GEP-NETs are the second most prevalent neoplasm of gastrointestinal origin after colorectal cancer. Since publication of the AJCC eighth edition, the World Health Organization has updated the classification and separates grade 3 GEP-NETs from poorly differentiated neuroendocrine carcinoma...
April 29, 2024: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/38683155/management-of-advanced-medullary-thyroid-carcinoma-current-systemic-therapy-options
#9
REVIEW
Mark A Jara
The current rapid development of more selective and effective drugs for the treatment of thyroid cancer has open a new era in the treatment of patients with this condition, in the past limited to the possibility of only radioactive iodine for well differentiated tumor and surgery for medullary thyroid carcinoma (MTC). The treatment of advanced medullary thyroid carcinoma has evolved in the last few years and options for patients with advanced disease are now available. Multikinase inhibitors (MKIs) with nonselective RET inhibition like Vandetanib and Cabozantinib were approved for the treatment of MTC, although the efficacy is limited due to the lack of specificity resulting in a higher rate of drug-related adverse events, leading to subsequent dose reductions, or discontinuation, and the development of a resistance mechanism like seen on the RET Val804 gatekeeper mutations...
2024: Critical Reviews in Oncogenesis
https://read.qxmd.com/read/38682424/prognostic-significance-of-nodal-micrometastases-of-non-functioning-pancreatic-neuroendocrine-tumours
#10
JOURNAL ARTICLE
Valentina Andreasi, Stefano Partelli, Marco Schiavo Lena, Francesca Muffatti, Anna Battistella, Domenico Tamburrino, Nicolò Pecorelli, Stefano Crippa, Gianpaolo Balzano, Claudio Doglioni, Massimo Falconi
No abstract text is available yet for this article.
April 3, 2024: British Journal of Surgery
https://read.qxmd.com/read/38680861/case-report-rare-case-of-a-preoperatively-diagnosed-spermatic-cord-paraganglioma-and-literature-review
#11
Yining Hao, Xiuci Li, Jing Xie, Wei He, Chenghe Wang, Fukang Sun
Paraganglioma (PGL) is rare, and PGL that arises from the urogenital system is even rarer. Here we report a case of PGL in spermatic cord and review the relevant literatures. We encountered a 15-year-old boy with a history of hypertension for almost 2 years, accompanied with headache and palpitations. His serum and urine catecholamines were elevated, but no adrenal lesions were detected, suggesting the existence of PGL. Upon physical examination, a painless nodule adherent to the spermatic cord in the right scrotum was found...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38680860/the-expression-of-pkm1-and-pkm2-in-developing-benign-and-cancerous-prostatic-tissues
#12
JOURNAL ARTICLE
Lin Li, Siyuan Cheng, Yunshin Yeh, Yingli Shi, Nikayla Henderson, David Price, Xin Gu, Xiuping Yu
BACKGROUND: Neuroendocrine prostate cancer (NEPCa) is the most aggressive type of prostate cancer (PCa). However, energy metabolism, one of the hallmarks of cancer, in NEPCa has not been well studied. Pyruvate kinase M (PKM), which catalyzes the final step of glycolysis, has two main splicing isoforms, PKM1 and PKM2. The expression pattern of PKM1 and PKM2 in NEPCa remains unknown. METHODS: In this study, we used immunohistochemistry, immunofluorescence staining, and bioinformatics analysis to examine the expression of PKM1 and PKM2 in mouse and human prostatic tissues...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38679679/presacral-neuroendocrine-neoplasms-a-multi-site-review-of-surgical-outcomes
#13
JOURNAL ARTICLE
Tommaso Violante, Brenda Murphy, Davide Ferrari, Rondell P Graham, Patrick Navin, Amit Merchea, David W Larson, Eric J Dozois, Thorvardur R Halfdanarson, William R Perry
INTRODUCTION: Presacral neuroendocrine neoplasms (PNENs) are rare tumors, with limited data on management and outcomes. METHODS: A retrospective review of institutional medical records was conducted to identify all patients with PNENs between 2008 and 2022. Data collection included demographics, symptoms, imaging, surgical approaches, pathology, complications, and long-term outcomes. RESULTS: Twelve patients were identified; two-thirds were female, averaging 44...
April 28, 2024: Annals of Surgical Oncology
https://read.qxmd.com/read/38678333/-intraspinal-composite-gangliocytoma-neuroma-and-neuroendocrine-tumor-with-vascular-malformation-report-of-a-case
#14
JOURNAL ARTICLE
Y Li, H J Ti, J Fu, B Jiang
No abstract text is available yet for this article.
May 8, 2024: Zhonghua Bing Li Xue za Zhi Chinese Journal of Pathology
https://read.qxmd.com/read/38678324/-acidophil-stem-cell-pituitary-neuroendocrine-tumors-adenoma-a-clinicopathological-analysis-of-five-cases
#15
JOURNAL ARTICLE
L Lou, S X Du, Y T Fu, Q Q Shao, W L Guo, Y P Zong, M M Qin, X X Tian, Y H Li
Objective: To investigate the clinicopathological characteristics of acidophil stem cell pituitary neuroendocrine tumors (PitNET)/adenoma. Methods: Five cases of acidophil stem cell PitNET/adenoma were diagnosed between May 2022 and July 2023 at the Second Hospital of Hebei Medical University, Shijiazhuang, China. The clinicopathological features of the tumor were analyzed by using histology, immunohistochemistry, and electron microscopy. The relevant literature was reviewed. Results: There were 1 male and 4 females, aged from 23 to 69 years...
May 8, 2024: Zhonghua Bing Li Xue za Zhi Chinese Journal of Pathology
https://read.qxmd.com/read/38678248/a-rare-case-of-neuroendocrine-cell-tumor-mixed-with-a-mucinous-component-in-the-ampulla-of-vater
#16
JOURNAL ARTICLE
Tamotus Sugai, Noriyuki Uesugi, Masamichi Suzuki, Nobuyasu Suzuki, Michitaka Honda, Tsuyoshi Abe, Naoki Yanagawa
BACKGROUND: A rare case of neuroendocrine cell tumor (NET) having both conventional and mucinous components was reported. Mucinous NET is rarely encountered in the pathological diagnosis of gastrointestinal (GI) tumors. Here we examined the mechanism for transformation of conventional NETs into mucinous NETs. CASE PRESENTATION: Macroscopic examination revealed a tumor with ulceration in the ampulla of Vater that measured 1.7 cm in its largest diameter. Histologically, the tumor comprised two components: a tubular/ribbon-like feature and small nests floating in a mucinous lake...
April 27, 2024: Diagnostic Pathology
https://read.qxmd.com/read/38677983/multicenter-validation-study-of-a-treatment-selection-map-for-pancreatic-neuroendocrine-tumors
#17
JOURNAL ARTICLE
Masafumi Ikeda, Susumu Hijioka, Tetsuhide Ito, Shigemi Matsumoto, Yoshitaka Honma, Makoto Ueno, Naohiro Okano, Taku Aoki, Junji Furuse
BACKGROUND: Somatostatin analogs, molecular-targeted agents and cytotoxic anticancer agents are available as therapeutic agents for the systemic treatment of pancreatic neuroendocrine tumors, and we have developed a first-line treatment selection MAP to enable selection of the optimal treatment strategy for pancreatic neuroendocrine tumors. The purpose of this study was to validate the usefulness of the treatment selection MAP. METHODS: Patients who had received systemic therapy for a pancreatic neuroendocrine tumor between January 2017 and December 2020 were compared according to whether they had been treated as recommended by the MAP (matched patients) or not (unmatched patients) to determine whether better outcomes were achieved by the matched patients...
April 27, 2024: Japanese Journal of Clinical Oncology
https://read.qxmd.com/read/38677640/immune-landscape-and-progress-in-immunotherapy-for-pituitary-neuroendocrine-tumors
#18
REVIEW
Xiaopeng Guo, Yiying Yang, Zhihong Qian, Mengqi Chang, Yuanli Zhao, Wenbin Ma, Yu Wang, Bing Xing
Pituitary neuroendocrine tumors (pitNETs) are the second most common primary brain tumors. Despite their prevalence, the tumor immune microenvironment (TIME) and its clinical implications remain largely unexplored. This review provides a comprehensive overview of current knowledge on the immune landscape and advancements in targeted immunotherapy for pitNETs. Macrophages and T cells are principal immune infiltrates within the TIME. Different subtypes of pitNETs display distinct immune patterns, influencing tumor progressive behaviors...
April 25, 2024: Cancer Letters
https://read.qxmd.com/read/38676802/patient-derived-xenograft-models-for-translational-prostate-cancer-research-and-drug-development
#19
JOURNAL ARTICLE
Lisa Kate Philp
Patient-derived xenografts (PDXs) are a valuable preclinical research platform generated through transplantation of a patient's resected tumor into an immunodeficient or humanized mouse. PDXs serve as a high-fidelity avatar for both precision medicine and therapeutic testing against the cancer patient's disease state. While PDXs show mixed response to initial establishment, those that successfully engraft and can be sustained with serial passaging form a useful tool for basic and translational prostate cancer (PCa) research...
2024: Methods in Molecular Biology
https://read.qxmd.com/read/38674926/mechanism-of-action-of-melatonin-as-a-potential-adjuvant-therapy-in-inflammatory-bowel-disease-and-colorectal-cancer
#20
REVIEW
Abdo Jurjus, Jad El Masri, Maya Ghazi, Lemir Majed El Ayoubi, Lara Soueid, Alice Gerges Geagea, Rosalyn Jurjus
Inflammatory bowel disease (IBD), a continuum of chronic inflammatory diseases, is tightly associated with immune system dysregulation and dysbiosis, leading to inflammation in the gastrointestinal tract (GIT) and multiple extraintestinal manifestations. The pathogenesis of IBD is not completely elucidated. However, it is associated with an increased risk of colorectal cancer (CRC), which is one of the most common gastrointestinal malignancies. In both IBD and CRC, a complex interplay occurs between the immune system and gut microbiota (GM), leading to the alteration in GM composition...
April 21, 2024: Nutrients
keyword
keyword
85606
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.